NGVT Ingevity Corp

Price (delayed)

$39.27

Market cap

$1.42B

P/E Ratio

11.28

Dividend/share

N/A

EPS

$3.48

Enterprise value

$2.88B

Ingevity provides specialty chemicals, high-performance carbon materials and engineered polymers that purify, protect and enhance the world around us. Through a team of talented and experienced people, Ingevity develops, manufactures, ...

Highlights
NGVT's P/E is 34% below its 5-year quarterly average of 17.0 and 13% below its last 4 quarters average of 13.0
The equity has grown by 13% YoY
The debt is up by 28% YoY but it is down by 3.2% from the previous quarter
The company's revenue rose by 5% YoY but it fell by 2.1% QoQ
NGVT's net income is down by 44% YoY and by 28% QoQ
The EPS is down by 41% year-on-year and by 27% since the previous quarter

Key stats

What are the main financial stats of NGVT
Market
Shares outstanding
36.23M
Market cap
$1.42B
Enterprise value
$2.88B
Valuations
Price to book (P/B)
1.98
Price to sales (P/S)
0.83
EV/EBIT
11.41
EV/EBITDA
7.26
EV/Sales
1.69
Earnings
Revenue
$1.7B
EBIT
$252.4M
EBITDA
$396.7M
Free cash flow
$128.9M
Per share
EPS
$3.48
Free cash flow per share
$3.56
Book value per share
$19.84
Revenue per share
$47.04
TBVPS
$51.65
Balance sheet
Total assets
$2.77B
Total liabilities
$2.05B
Debt
$1.54B
Equity
$718.7M
Working capital
$429.4M
Liquidity
Debt to equity
2.15
Current ratio
2.41
Quick ratio
0.99
Net debt/EBITDA
3.67
Margins
EBITDA margin
23.3%
Gross margin
30.4%
Net margin
7.5%
Operating margin
13.5%
Efficiency
Return on assets
4.6%
Return on equity
17.8%
Return on invested capital
8.3%
Return on capital employed
10.3%
Return on sales
14.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NGVT stock price

How has the Ingevity stock price performed over time
Intraday
1.08%
1 week
-0.53%
1 month
-1.97%
1 year
-46.64%
YTD
-44.25%
QTD
-17.52%

Financial performance

How have Ingevity's revenue and profit performed over time
Revenue
$1.7B
Gross profit
$517.8M
Operating income
$230.3M
Net income
$127M
Gross margin
30.4%
Net margin
7.5%
The net margin is down by 46% YoY and by 26% from the previous quarter
NGVT's net income is down by 44% YoY and by 28% QoQ
NGVT's operating margin is down by 34% year-on-year and by 17% since the previous quarter
Ingevity's operating income has decreased by 31% YoY and by 19% from the previous quarter

Growth

What is Ingevity's growth rate over time

Valuation

What is Ingevity stock price valuation
P/E
11.28
P/B
1.98
P/S
0.83
EV/EBIT
11.41
EV/EBITDA
7.26
EV/Sales
1.69
The EPS is down by 41% year-on-year and by 27% since the previous quarter
NGVT's P/E is 34% below its 5-year quarterly average of 17.0 and 13% below its last 4 quarters average of 13.0
The P/B is 63% below the 5-year quarterly average of 5.3 and 38% below the last 4 quarters average of 3.2
The equity has grown by 13% YoY
NGVT's P/S is 60% below its 5-year quarterly average of 2.1 and 36% below its last 4 quarters average of 1.3
The company's revenue rose by 5% YoY but it fell by 2.1% QoQ

Efficiency

How efficient is Ingevity business performance
The ROA has plunged by 51% YoY and by 30% from the previous quarter
The ROE has declined by 48% year-on-year and by 30% since the previous quarter
Ingevity's ROIC has decreased by 41% YoY and by 21% from the previous quarter
The ROS is down by 29% year-on-year and by 15% since the previous quarter

Dividends

What is NGVT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NGVT.

Financial health

How did Ingevity financials performed over time
The total assets is 35% greater than the total liabilities
NGVT's total liabilities is up by 20% year-on-year but it is down by 3.1% since the previous quarter
The total assets has increased by 18% year-on-year but it has declined by 2.2% since the previous quarter
The debt is 115% more than the equity
The debt is up by 28% YoY but it is down by 3.2% from the previous quarter
The equity has grown by 13% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.